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ABSTRACT 
Vital roles of peptide/protein thioesters in protein chemistry, including chemical or semi synthesis of 
proteins, have encouraged studies on the development of methods for the preparation of such 
chemical units. Biochemical protocols using intein or sortase have proved to be useful in protein 
chemistry as methods suitable for naturally occurring sequences, including recombinant proteins. 
Although chemical protocols are potential options for thioester preparation, only a few are applicable 
to naturally occurring sequences, because standard chemical protocols require an artificial chemical 
device for producing thioesters. In this context, the chemical preparation of thioesters based on a 
reaction sequence consisting of regioselective S-cyanylation and hydrazinolysis was investigated. 
Regioselective S-cyanylation, which is required for cysteine-containing thioesters, was achieved 
with the aid of zinc-complex formation of a CCHH-type zinc-finger sequence. Free cysteine residues 
that are not involved in complex formation were selectively protected with a 6-nitroveratryl group 
followed by S-cyanylation of the zinc-binding cysteine. Hydrazinolysis of the resulting 
S-cyanopeptide and subsequent photo-removal of the 6-nitroveratryl group yielded the desired
peptide hydrazide, which was then converted to the corresponding thioester. The generated thioester 
was successfully used in N–to–C-directed one-pot/sequential native chemical ligation using an 
N-sulfanylethylanilide peptide to give a 64-residue peptide toxin.
INTRODUCTION 
Peptide thioesters have enjoyed increasingly widespread use in native chemical ligation (NCL),1 this 
technique enables chemical synthesis of small proteins to be easily achieved. Much effort has 
therefore been focused on the development of chemical or biochemical methods for the preparation 
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of peptide thioesters. Biochemical methods typified by the use of engineered intein2 or sortase3 
enable thioesters to be prepared from expressed proteins. However, such biochemical protocols do 
not always successfully produce peptide/protein thioesters, therefore other methods, such as 
chemical methods, need to be developed as alternatives to intein- or sortase-mediated protocols. 
Generally, chemical protocols require an unnatural structural scaffold as a chemical device for 
producing thioesters,4 therefore chemical methods have not been used for naturally occurring peptide 
sequences such as recombinant proteins. The increasing demand for chemical methods that are 
applicable to naturally occurring sequences has stimulated studies on the development of 
expressed-protein-compatible chemical methods for thioester preparation.5 Recently, innovations 
based on an acyl-transfer reaction have been made by several research groups, including ours,6 in 
which peptide hydrazides have served as indispensable intermediates for thioesters. The contribution 
by Liu and co-workers7 rekindled interest in peptide hydrazides, which can be converted to the 
corresponding peptide thioesters via peptide azides. Herein, we focus on the development of a new 
chemical method that enables the conversion of natural peptide sequences to peptide hydrazides. 
 
Scheme 1 
 
Initially, we paid attention to the S-cyanylation-induced hydrolysis of Xaa–Cys peptide bonds 
(Xaa: proteogenic amino acid) of cysteine-containing peptides 1 (Scheme 1A).8 S-Cyanylation of a 
cysteine residue followed by nucleophilic attack by a hydroxyl anion (NaOH in H2O) on the peptide 
bond at the N-terminal side of the cysteine induces hydrolysis to afford peptide acid 4 and 
2-iminothiazolidine-4-carbonyl (Itc)-capped peptide 6. Nishimura and co-workers reported that 
replacement of NaOH with NH3 in the hydrolysis reaction produced peptide amides 5, with practical 
applications to non-enzymatic conversion of recombinant proteins to peptide amides.9 This research 
prompted us to attempt hydrazinolysis of an S-cyanocysteine-containing peptide 2 to produce a 
peptide hydrazide 7 as a requisite precursor for thioesters 9 (Scheme 1B). In this paper, we report the 
S-cyanylation-mediated synthesis of peptide thioesters applicable to naturally occurring peptide 
sequences.10 
 
RESULTS AND DISCUSSION 
Cyanylation of monocysteinyl peptide and subsequent hydrazinolysis 
First, the feasibility of converting a cysteine-containing peptide to a peptide hydrazide was examined 
using a model cysteinyl peptide, Ac-LYRAACRANK-NH2 10a. Treatment of 10a with 
1-cyano-4-dimethylaminopyridinium tetrafluoroborate (CDAP)11 in 0.1 M AcOH in H2O afforded 
the corresponding S-cyanopeptide, Ac-LYRAAC(CN)RANK-NH2 11a. After high-performance 
liquid chromatography (HPLC) purification, reaction of 11a with 3 M NH2NH2·H2O in H2O 
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immediately went to completion to yield the desired peptide hydrazide Ac-LYRAA-NHNH2 12a in 
80% isolated yield as the major product. The concomitant formation of minor side products, 
including starting material 10a, a disulfide peptide, and a hydrazine -adduct peptide, was observed 
during hydrazinolysis. Modulation of the reaction conditions, including reaction temperature, time, 
and number of equivalents of reagents gave no significant improvement in the reaction outcome. We 
therefore concluded that the reaction in 1 to 3 M NH2NH2·H2O aqueous solution is generally 
applicable to the conversion of S-cyanopeptides to the corresponding peptide hydrazides. We next 
examined the applicability of the S-cyanylation–hydrazinolysis sequence to naturally occurring 
19-Xaa–Cys junctions using model peptides, Ac-LYRAXaaCRANK-NH2 10; the results are shown 
in Table 1. The reaction of model peptides 10a–r with CDAP in 0.1 M AcOH in H2O, followed by 
HPLC purification, efficiently produced the S-cyanopeptides, Ac-LYRAXaaC(CN)RANK-NH2 11. 
The purified S-cyanopeptides 11 were treated with 3 M NH2NH2·H2O aqueous solution at 0 °C to 
room temperature for 1 h to convert them to the corresponding peptide hydrazides 12; the results are 
summarized in Table 1. 
 
Table 1 Examination of conversion of model monocysteine peptides to peptide hydrazides. 
 
entry amino acid 
(Xaa) 
S-cyanopeptide product fraction converteda 
1 Ala 11a 12a 0.62 (80%)b 
2 Gly 11b 12b 0.67 
3 Leu 11c 12c 0.47 
4 Val 11d 12d 0.55 
5 Ile 11e 12e 0.47 
6 Met 11f 12f 0.67 
7 Pro 11g 12g 0.57 
8 Phe 11h 12h 0.59 
9 Tyr 11i 12i 0.36 
10 Trp 11j 12j 0.52 
11 His 11k 12k 0.55 
12 Lys 11l 12l 0.55 
13 Arg 11m 12m 0.78 
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14 Ser 11n 12n 0.77 
15 Thr 11o 12o 0.76 
16 Asp 11p 12p 0.33 
17 Glu 11q 12q 0.43 
18 Asn 11r 12r —c 
19 Gln 11s 12s 0.64 
aThe fraction converted was determined by integration of 12 as a fraction of the 
sum of integration of 12 + other detected peptides. bIsolated yield of 
HPLC-purified 12a. cAfter 1 h reaction, desired peptide 12 r was not obtained. 
 
It has been reported that in S-cyanylation-meditated hydrolysis and amidation, amino acids located 
at the N-terminal side of the cyanocysteine affect the molecular form of the cleavage products.12 
Acidic residues (Asp and Glu) were reported to cause problems arising from preferential formation 
of a dehydroalanine residue at the cysteine site. The junctions between bulky hydrophobic residues 
and cysteine are also unfavorable for the amidation reaction. The formations of aspartimide from an 
Asn residue seemed to be an issue in hydrazinolysis.  
Except for the initially concerned residues such as Leu, Ile, Tyr, Trp, Asp, Glu, and Asn, fraction 
conversion of over 55% was achieved. Although the short reaction of Asn-containing S-cyanopeptide 
11r afforded the desired hydrazide 12r with concomitant formation of several byproducts, including 
a C-terminal aspartimide peptide, continuous reaction for 1 h resulted in complete disappearance of 
12r to produce a complex mixture containing six-membered diacyl hydrazide peptide 12r’. These 
results convinced us that appropriate choice of the scission junction would make 
S-cyanylation-mediated hydrazinolysis a naturally occurring sequence-compatible chemical method 
for thioester. However, one potential limitation of this method is that it is essentially limited to 
monocysteine-containing precursor peptides to afford non-cysteinyl thioesters, i.e., the developed 
protocol is only widely applicable various peptide/proteins when regioselective S-cyanylation of the 
scissile cysteine residue among several cysteine residues can be achieved. 
 
Regioselective S-cyanylation using zinc-finger domain followed by hydrazinolysis 
 
Scheme 2 
 
We next explored a procedure applicable to the preparation of cysteinyl peptidyl thioesters, based on 
regioselective S-cyanylation at the Xaa–Cys junction transformable to the Xaa–thioester. As shown 
in Scheme 2, we used a zinc-finger peptide sequence13,14 for the regioselective S-cyanylation, in 
which coordination of Cys and His residues to a zinc cation leads to temporary protection of the Cys 
residue that should undergo S-cyanylation (13 to 14). Then, protection of Cys residues in a peptide 
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of interest (POI) by an appropriate protecting group, followed by removal of zinc and subsequent 
S-cyanylation, should furnish the requisite S-cyanopeptide (14 to 16). Hydrazinolysis of the 
S-cyanopeptide 16 would result in cleavage of the desired amide bond at the Xaa–S-cyanocysteine 
junction to yield peptide hydrazide 17. In the envisioned sequence of reactions, we initially 
attempted to use an S-sulfonate group15 to protect Cys residues in the POI, because introduction of 
the sulfonate group could be performed after zinc-complex formation without isolation of the 
complex, and the thiol treatment involved in conversion of hydrazides to thioesters could remove the 
S-sulfonate group to regenerate the Cys residue. 
 
Figure 1  
 
The third C2H2-type zinc-finger sequences (-FACDICGRKFARSDERKRHTKIHLRQKD- and 
its F1A2-F1Q2 mutant) present in the mouse transcription factor Zif268,13 one of the 
best-characterized finger domains, were selected as the zinc-finger domain fused to POIs. Generally, 
zinc-fingers adopt a globular  structure, and the N-terminal residue (Phe) has been reported to be 
important for folding into the  structure to form a stable zinc-complex.16 Taking this requirement 
into consideration, we attempted the preparation of conotoxin 117 (H-GCCGAFA-SR) and 
Stichodactyla toxin18 (H-RSCIDTIPKSRCTAFQ-SR) thioester fragments, using the envisioned 
regioselective S-cyanylation-mediated hydrazinolysis protocol. 
As shown in Figure 1, a chemically synthesized conotoxin/zinc-finger fusion, H- 
GCCGAFA-CDICGRKFARSDERKRHTKIHLRQKD-NH2 19, was initially incubated in 20 mM 
3-[4-(2-hydroxyethyl)-1-piperazinyl]propanesulfonic acid (HEPPS) at pH 7.0 in the presence of 5 
equiv of ZnCl2 to form a zinc-finger complex, and then Na2SO3 (123 equiv) and Na2S4O6 (23 equiv) 
were added to the reaction mixture to incorporate S-sulfonate groups on the cysteine residues of the 
conotoxin sequence. Reaction at pH 7.0 for 24 h proceeded efficiently to yield the desired 
di-S-sulfonate peptide 21, which was then purified by HPLC using acidic eluents containing 
trifluoroacetic acid (TFA) for concomitant removal of zinc cations. The resulting eluents were 
treated with CDAP in aqueous 0.1 M AcOH, without lyophilization, to perform S-cyanylation of the 
cysteine residues of the zinc-finger sequence. The reaction proceeded quantitatively to produce the 
desired di-S-sulfonyl-di-S-cyanopeptide 22. With the requisite regioselectively S-cyanylated peptide 
in hand, we subjected the resulting peptide 22 to hydrazinolysis with 3 M NH2NH2·H2O at room 
temperature for 2.5 h. The reaction unambiguously yielded the desired hydrazide peptide, 
H-GC(S-SO3H)C(S-SO3H)GAFA-NHNH2 23, along with two 2-iminothiazolidine-4-carbonyl 
(Itc)-capped peptides, but a complex mixture consisting of various peptides was obtained. A similar 
trend was observed in the case of hydrazinolysis of the di-S-sulfonyl-di-S-cyanopeptide derived from 
a Stichodactyla toxin precursor, resulting in formation of a complex mixture.  
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Analyses of the undesired materials in both cases indicated that one potential reason for the 
unsatisfactory outcome was hydrazinolysis-mediated loss of the cyano group on the cysteine residue, 
followed by disulfide bond formation between the S-sulfonylcysteine and regenerated cysteine 
residues.19 Instead of the S-sulfonate group, we initially examined disulfide-type protections such as 
S–S-methyl20 and S–S-tert-butyl21 groups, because methylamine-mediated aminolysis of a 
disulfide-bond-containing S-cyanopeptide was reported to be possible.22 However, the use of 
disulfide protection for hydrazinolysis failed to afford the desired peptides preferentially. 
While we were performing our research, the selective S-alkylation of a zinc-finger sequence-fused 
cysteinyl peptide was reported for the chemoselective synthesis of a DNA-binding zinc-finger 
derivative,14 in which an alkylation reaction with benzyl bromoacetate in the presence of ZnSO4 in 
phosphate buffer was used. Using this example as a reference, we next tried to perform selective 
S-alkylation of the Stichodactyla toxin zinc-finger-fused 24 as shown in Figure 2.  
 
Figure 2 
 
Removal of the introduced S-protection under non-denaturing conditions, without added reagents, is 
desirable; therefore, we selected the 6-nitroveratryl (NV) group as a photocleavable S-protection.23 A 
solution of peptide 24 in 10 mM phosphate buffer at pH 7.5 in the presence of 1.5 equiv of ZnSO4 
was treated with 3 equiv of 6-nitroveratryl bromide (NV-Br) at ambient temperature for 2 h. The 
reaction proceeded efficiently to yield the desired di-S-NV peptide 25, which was then directly used 
in the subsequent reaction with CDAP at ambient temperature for 1.5 h to yield the desired 
di-S-NV-di-S-cyanopeptide 26. HPLC purification gave the desired peptide 26 in 51% isolated yield. 
HPLC analysis of the reaction of the resulting peptide with 3 M NH2NH2 in H2O at 0 °C for 1 h 
showed that it proceeded efficiently, affording the desired hydrazide 27 and Itc-capped peptides 
(Figure 2-B, iv). 
However, in HPLC analysis of the tris(2-carboxyethyl)phosphine (TCEP)-treated reaction mixture, a 
di-S-NV peptide without two cyano groups 28 appeared as a peak separate from that of desired 
peptide 27 (Figure 2-B, v). This indicated that hydrazinolysis afforded the desired hydrazide 27 and 
di-S-NV disulfide peptide 28, which was formed by intramolecular disulfide bond formation 
between S-cyanocysteine and cysteine resulting from NH2NH2-mediated loss of the cyano group. 
Although such loss of the cyano group during NH2NH2 treatment was also observed in previous 
attempts described above, regenerated thiol groups did not cause a serious problem because the 
S-NV group remained intact. Furthermore, the formed disulfide peptide was reconverted to the 
substrate peptide required for the hydrazinolysis reaction by reduction and subsequent S-cyanylation. 
 
Figure 3 
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 The desired di-S-NV peptide hydrazide 27 was purified by HPLC using acidic eluents, followed by 
lyophilization, which led to another issue of concern. 
Part of the purified sample was converted to another component with the desired molecular weight 
minus 17 mass units. We speculated that the seven-membered cyclic diacyl hydrazide peptide 29 was 
formed, as observed in the case of the Asn–Cys(CN) junction. Lyophilization under acidic conditions 
was confirmed to be responsible for the formation of the cyclic diacyl hydrazide peptide 29, because 
HPLC purification of 27 with neutral eluents (10 mM NH4OAc buffer, pH 6.8) followed by 
lyophilization did not afford any cyclized diacyl hydrazide.24 The peptide sequence producing the 
Gln-NHNH2 was not suitable for experiments for fixing the precise reaction conditions. The S-NV 
groups were removed using the peptide mixture. Photoirradiation of the peptide mixture in a 
photolysis buffer25 (50 mM semicarbazide·HCl, 20 mM ascorbic acid in MeCN-50 mM phosphate 
buffer (1:1), pH 6.0) at 365 nm at ambient temperature for 3 h triggered efficient removal of the 
S-NV group.                       
 
Thioester synthesis using regioselective S-cyanylation/hydrazinolysis sequence and practical 
application to synthesis of TsTxV toxin 
 
As shown in Figure 4, for more precise experiments, the substrate peptide sequence was changed to 
a scorpion toxin, TsTxV,26 N-terminal fragment (1–15)-zinc-finger fusion 30 
(H-KKDGYPVEGDNCAFA- CDICGRKFARSDERKRHTKIHLRQKD-NH2). Reaction of 30 in 
10 mM phosphate buffer, pH 7.5, in the presence of 1.5 equiv of ZnSO4 with 1.7 equiv of 6-NV-Br 
at ambient temperature for 6 h went to completion to give the desired mono-S-NV peptide 31 
preferentially, accompanied by a small amount of tri-NV peptide. Then, CDAP in aqueous 0.1 M 
AcOH was added to the resulting reaction mixture and the pH was adjusted to around 5.0 to perform 
S-cyanylation. The sequence of reactions yielded the desired mono-S-NV-S,S-dicyanopeptide 32 in 
54% isolated yield. Hydrazinolysis of the resulting peptide 32 with 1 M NH2NH2 in 1 M Gn·HCl–33 
mM phosphate buffer, pH 10.4, at ambient temperature for 7 h proceeded without precipitate 
formation. Optimal concentration of hydrazine varies according to peptides, preliminary experiment 
for TsTxV indicated that the use of this reaction conditions afforded the best result so far examined. 
The reaction mixture was then incubated at 37 °C in the presence of 30 mM TCEP for reduction of 
the disulfide peptide formed during hydrazinolysis to give a mixture of the desired S-mono-NV 
hydrazide 33, S-mono-NV-sulfanylpeptide 34, and the C-terminal halves. HPLC purification of the 
mixture gave 33 and 34 in 38% and 16% isolated yields, respectively. Because the resulting 
byproduct, sulfanyl peptide 34, can be recycled to afford 33, loss of the cyano group is not a serious 
problem unless the S-protection is unsusceptible to the regenerated sulfanyl group as the NV group.  
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Figure 4 
 
Photoirradiation of 33 in photolysis buffer (50 mM semicarbazide·HCl, 20 mM ascorbic acid in 
MeCN-50 mM phosphate buffer (1:1), pH 6.0) under a 365 nm UV lamp at ambient temperature for 
3 h yielded S-deprotected peptide 35 in 59% isolated yield after HPLC purification. The resulting 
peptide hydrazide 35 was successfully converted to the corresponding peptide thioester, according to 
Liu’s protocol. HPLC purification gave purified 36 in 85% isolated yield (Figure 5).  
 
Figure 5 
 
Thioester 36 was used to assemble a chain covering the entire sequence of TsTxV, based on 
N-sulfanylethylanilide (SEAlide) peptide-mediated N–to–C-directed one-pot/sequential NCL27 as 
shown in Figure 6. The requisite peptide fragments 37 and 38, corresponding to TsTxV 16–37 and 
38–64, respectively, were prepared by 9-fluorenylmethyloxycarbonyl (Fmoc) solid-phase peptide 
synthesis (SPPS). The first NCL of alkyl thioester 36 with N-terminal cysteinyl SEAlide peptide 37 
was performed in 6 M Gd·HCl–0.2 M HEPPS buffer, pH 7.0, in the presence of 200 mM 
4-mercaptophenylacetic acid (MPAA) and 50 mM TCEP for 3 h at 37 °C to yield ligated SEAlide 
peptide 39 (36 + 37). During the first NCL, the absence of phosphate salts enabled the SEAlide 
moiety, as a crypto thioester, to remain intact. Then, a 1 M phosphate buffer solution of peptide 38 
was added to the resulting reaction mixture to initiate the second NCL to yield the desired reduced 
form TsTxV 40 in 31% isolated yield after HPLC purification. 
 
Figure 6 
 
In the zinc-finger sequence, the two N-terminal amino acid residues adjacent to the cysteine are 
important for folding the  structure responsible for zinc-complex formation. The severe 
restriction on the N-terminal residues in the zinc-finger diminishes the usefulness of the developed 
protocol, therefore mutations were incorporated into the TsTxV fragment–zinc-finger fusion and 
their effects were examined (Table 2). Although not all possible mutations were investigated, 
substitutions of Phe or Ser for Ala, or of Ala for Phe, were acceptable for the regioselective 
S-cyanylation/hydrazinolysis reaction. 
 
Table 2 Effects of the N-terminal sequence on regioselective cyanylation/hydrazinolysis sequence. 
entrya 
N-terminal 
sequence 
regioselective cyanylationb 
(isolated yield by HPLC, %) 
hydrazinolysisc 
(isolated yield by HPLC, %) 
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original Phe–Ala 54 38 
1 Phe–Phe 63 36 
2 Phe–Ser 35d 65 
3 Ala–Ala 38d 38 
aPeptides, H-KKDGYPVEGDNCA-N-terminal sequence-CDICGRKFARSDERKRHTKIHLR- 
QKD-NH2, were subjected to regioselective cyanylation/hydrazinolysis sequence. bIsolated yield of 
H-KKDGYPVEGDNC(NV)A-N-terminal sequence-C(CN)DIC(CN)GRKFARSDERKRHTK- 
IHLRQKD-NH2. cIsolated yield of H-KKDGYPVEGDNCA-N-terminal sequence-NHNH2. 
dAlthough the cyanylation reaction proceeded in efficacy comparable to that of original or entry 1, 
loss of the desired material during HPLC purification resulted in low isolated yield. 
 
 
CONCLUSION 
In this study, a regioselective S-cyanylation/hydrazinolysis sequence for thioester preparation via a 
chemical method was developed. An important feature of this protocol is its applicability to naturally 
occurring peptide sequences, whereas previously developed chemical protocols require artificial 
chemical devices for producing thioesters. Another key point is achievement of a sequence of 
reactions consisting of zinc-complex formation on a zinc-finger sequence, S-6-nitroveratrylation and 
S-cyanylation, which guarantees regioselective S-cyanylation, enabling wide applicability to various 
peptide sequences. In this study, limitation of the zinc-finger N-terminal sequence required for 
keeping the  structure for zinc-complex formation was not a problem. With respect to this issue, 
research on application of this protocol to other peptide sequences will be continued. Further 
research on applications of this protocol to various peptides including recombinant ones is underway 
and the results will be presented in due course.  
 
Materials and Methods 
 
General Methods 
 
Mass spectra were recorded on a Waters MICROMASS® LCT PREMIERTM. For HPLC separations, 
a Cosmosil 5C18-AR-II analytical column (Nacalai Tesque, 4.6 × 250 mm, flow rate 1.0 mL/min), a 
TSKgel Octadecyl-2PW analytical column (TOSOH CORPORATION, 4.6 × 150 mm, flow rate 1.0 
mL/min), a Cosmosil 5C18-AR-II semi-preparative column (Nacalai Tesque, 10 × 250 mm, flow 
rate 3.0 mL/min), or a Cosmosil 5C18-AR-II preparative column (Nacalai Tesque, 20 × 250 mm, 
flow rate 10 mL/min) was employed, and eluting products were detected by UV at 220 nm. A 
solvent system consisting of 0.1% TFA aqueous solution (v/v, solvent A) and 0.1% TFA in MeCN 
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(v/v, solvent B) was used for HPLC elution.  
 
Preparation of model Peptides 10a–s for Cyanylation 
 
Protected peptide resins corresponding to the title peptides were constructed on NovaSyn® TGR 
resin (Rink amide type: 0.22 mmol amine/g, 0.10 g, 0.022 mmol) using standard Fmoc SPPS. TFA 
cleavage (TFA-m-cresol-thioanisole-H2O-1,2-ethanedithiol (80:5:5:5:5 (v/v), 50 L/1 mg resin)) of 
the protected resins at room temperature for 2 h followed by HPLC purification afforded the desired 
peptides. 
10a (X = Ala) (45% isolated yield): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical 
column with a linear gradient of solvent B in solvent A, 1% to 30% over 30 min, retention time = 
24.1 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 10% to 30% 
over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 603.8, found 603.9. 
10b (X = Gly) (41% isolated yield): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical 
column with a linear gradient of solvent B in solvent A, 1% to 30% over 30 min, retention time = 
21.9 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 10% to 30% 
over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 596.8, found 596.9. 
10c (X =Leu) (59% isolated yield): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical 
column with a linear gradient of solvent B in solvent A, 10% to 40% over 30 min, retention time = 
20.6 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 10% to 30% 
over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 624.8, found 624.9. 
10d (X = Val) (35% isolated yield): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical 
column with a linear gradient of solvent B in solvent A, 10% to 40% over 30 min, retention time = 
17.4 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 10% to 30% 
over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 617.8, found 617.8. 
10e (X = Ile) (63% isolated yield): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical 
column with a linear gradient of solvent B in solvent A, 10% to 40% over 30 min, retention time = 
19.6 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 18% to 33% 
over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 624.8, found 624.9. 
10f (X = Met) (54% isolated yield): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical 
column with a linear gradient of solvent B in solvent A, 1% to 35% over 30 min, retention time = 
25.1 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 10% to 30% 
over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 633.8, found 633.9. 
10g (X = Pro) (41% isolated yield): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical 
column with a linear gradient of solvent B in solvent A, 1% to 30% over 30 min, retention time = 
22.7 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 10% to 30% 
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over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 616.8, found 616.8. 
10h (X = Phe) (61% isolated yield): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical 
column with a linear gradient of solvent B in solvent A, 10% to 40% over 30 min, retention time = 
21.0 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 18% to 33% 
over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 641.8, found 641.9. 
10i (X = Tyr) (55% isolated yield): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical 
column with a linear gradient of solvent B in solvent A, 10% to 40% over 30 min, retention time = 
17.0 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 15% to 35% 
over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 649.8, found 649.8. 
10j (X = Trp) (67% isolated yield): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical 
column with a linear gradient of solvent B in solvent A, 5% to 35% over 30 min, retention time = 
26.1 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 12% to 32% 
over 30 min. MS (ESI-TOF) m/z calcd ([M + 2H]2+) 661.3, found 661.4. 
10k (X = His) (41% isolated yield): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical 
column with a linear gradient of solvent B in solvent A, 1% to 30% over 30 min, retention time = 
21.5 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 15% to 35% 
over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 636.8, found 636.9. 
10l (X = Lys) (70% isolated yield): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical 
column with a linear gradient of solvent B in solvent A, 1% to 30% over 30 min, retention time = 
21.2 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 10% to 30% 
over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 632.4, found 632.4. 
10m (X = Arg) (61% isolated yield): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical 
column with a linear gradient of solvent B in solvent A, 1% to 25% over 30 min, retention time = 
24.9 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 10% to 30% 
over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 646.4, found 646.4. 
10n (X = Ser) (57% isolated yield): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical 
column with a linear gradient of solvent B in solvent A, 1% to 30% over 30 min, retention time = 
22.3 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 10% to 30% 
over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 611.8, found 611.9. 
10o (X = Thr) (54% isolated yield): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical 
column with a linear gradient of solvent B in solvent A, 1% to 30% over 30 min, retention time = 
23.0 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 10% to 30% 
over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 618.8, found 618.9. 
10p (X = Asp) (39% isolated yield): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical 
column with a linear gradient of solvent B in solvent A, 1% to 30% over 30 min, retention time = 
22.3 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 10% to 30% 
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over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 625.8, found 625.9. 
10q (X = Glu) (51% isolated yield): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical 
column with a linear gradient of solvent B in solvent A, 5% to 35% over 30 min, retention time = 
18.5 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 10% to 30% 
over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 632.8, found 632.8. 
10r (X = Asn) (65% isolated yield): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical 
column with a linear gradient of solvent B in solvent A, 1% to 30% over 30 min, retention time = 
21.6 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 10% to 30% 
over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 625.3, found 625.4. 
10s (X = Gln) (65% isolated yield): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical 
column with a linear gradient of solvent B in solvent A, 5% to 35% over 30 min, retention time = 
17.3 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 10% to 30% 
over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+), 632.3 found 632.3.  
 
S-Cyanylation of Peptides 10a–s 
 
Representative procedure: To a solution of peptide 10a (1.0 mol, 1.6 mg) in 0.1 M AcOH (160 L) 
was added the solution of 1-cyano-4-dimethylaminopyridinium tetrafluoroborate (CDAP) in 0.1 M 
AcOH (10 mg/mL, 72 L). After being stirred at room temperature for 1 h, the solution was purified 
by preparative HPLC to give the purified cyanylated peptide 11a (1.4 mg, 0.90 mol, 88%). 
11a (X = Ala): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a linear 
gradient of solvent B in solvent A, 1% to 30% over 30 min, retention time = 25.0 min. Preparative 
HPLC conditions: A linear gradient of solvent B in solvent A, 10% to 30% over 30 min. MS 
(ESI-TOF) m/z calcd ([M+2H]2+) 616.3, found 616.3. 
11b (X = Gly) (1.4 mg, 0.87 mol, 79%): Analytical HPLC conditions: Cosmosil 5C18-AR-II 
analytical column with a linear gradient of solvent B in solvent A, 1% to 30% over 30 min, retention 
time = 22.7 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 10% to 
30% over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 609.3, found 609.3. 
11c (X =Leu) (2.4 mg, 1.5 mol, 75%): Analytical HPLC conditions: Cosmosil 5C18-AR-II 
analytical column with a linear gradient of solvent B in solvent A, 10% to 40% over 30 min, 
retention time = 21.5 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 
17% to 32% over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 637.3, found 637.4. 
11d (X = Val) (1.7 mg, 1.1 mol, 89%): nalytical HPLC conditions: Cosmosil 5C18-AR-II analytical 
column with a linear gradient of solvent B in solvent A, 10% to 40% over 30 min, retention time = 
18.4 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 17% to 32% 
over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 630.3 found 630.3. 
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11e (X = Ile) (3.3 mg, 2.0 mol, 89%): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical 
column with a linear gradient of solvent B in solvent A, 10% to 40% over 30 min, retention time = 
20.5 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 18% to 33% 
over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 637.3, found 637.3. 
11f (X = Met) (3.0 mg, 1.8 mol, 91%): Analytical HPLC conditions: Cosmosil 5C18-AR-II 
analytical column with a linear gradient of solvent B in solvent A, 1% to 35% over 30 min, retention 
time = 25.8 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 17% to 
32% over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 646.3, found 646.4. 
11g (X = Pro) (2.1 mg, 1.3 mol, 85%): Analytical HPLC conditions: Cosmosil 5C18-AR-II 
analytical column with a linear gradient of solvent B in solvent A, 1% to 30% over 30 min, retention 
time = 23.6 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 12% to 
27% over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 629.3, found 629.3. 
11h (X = Phe) (1.4 mg, 0.85 mol, 82%): Analytical HPLC conditions: Cosmosil 5C18-AR-II 
analytical column with a linear gradient of solvent B in solvent A, 10% to 40% over 30 min, 
retention time = 21.8 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 
18% to 33% over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 654.3, found 654.2. 
11i (X = Tyr) (2.7 mg, 1.6 mol, 82%): Analytical HPLC conditions: Cosmosil 5C18-AR-II 
analytical column with a linear gradient of solvent B in solvent A, 10% to 40% over 30 min, 
retention time = 17.6 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 
17% to 32% over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 662.3, found 662.3. 
11j (X = Trp) (1.6 mg, 1.2 mol, 87%): Analytical HPLC conditions: Cosmosil 5C18-AR-II 
analytical column with a linear gradient of solvent B in solvent A, 5% to 35% over 30 min, retention 
time = 26.6 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 17% to 
32% over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 673.8, found 673.9. 
11k (X = His) (2.3 mg, 1.3 mol, 93%). Analytical HPLC conditions: Cosmosil 5C18-AR-II 
analytical column with a linear gradient of solvent B in solvent A, 1% to 25% over 30 min, retention 
time = 25.3 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 12% to 
27% over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 649.3, found 649.4. 
11l (X = Lys) (3.2 mg, 1.8 mol, 91%): Analytical HPLC conditions: Cosmosil 5C18-AR-II 
analytical column with a linear gradient of solvent B in solvent A, 1% to 30% over 30 min, retention 
time = 21.7 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 12% to 
27% over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 644.9, found 644.9. 
11m (X = Arg) (3.4 mg, 1.9 mol, 96%): Analytical HPLC conditions: Cosmosil 5C18-AR-II 
analytical column with a linear gradient of solvent B in solvent A, 1% to 25% over 30 min, retention 
time = 25.2 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 12% to 
27% over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 658.9, found 658.9. 
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11n (X = Ser) (1.5 mg, 0.94 mol, 74%): Analytical HPLC conditions: Cosmosil 5C18-AR-II 
analytical column with a linear gradient of solvent B in solvent A, 1% to 30% over 30 min, retention 
time = 22.8. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 12% to 27% 
over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 624.3, found 624.3. 
11o (X = Thr) (1.7 mg, 1.1 mol, 95%): Analytical HPLC conditions: Cosmosil 5C18-AR-II 
analytical column with a linear gradient of solvent B in solvent A, 1% to 30% over 30 min, retention 
time = 23.6 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 10% to 
30% over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 631.3, found 631.3. 
11p (X = Asp) (1.4 mg, 0.88 mol, 83%): Analytical HPLC conditions: Cosmosil 5C18-AR-II 
analytical column with a linear gradient of solvent B in solvent A, 1% to 30% over 30 min, retention 
time = 23.1 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 10% to 
30% over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 638.3, found 638.3. 
11q (X = Glu) (2.7 mg, 1.7 mol, 83%): Analytical HPLC conditions: Cosmosil 5C18-AR-II 
analytical column with a linear gradient of solvent B in solvent A, 5% to 35% over 30 min, retention 
time = 19.0 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 12% to 
27% over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 645.3, found 645.3. 
11r (X = Asn) (2.6 mg, 1.6 mol, 79%). Analytical HPLC conditions: Cosmosil 5C18-AR-II 
analytical column with a linear gradient of solvent B in solvent A, 1% to 30% over 30 min, retention 
time = 22.3 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 12% to 
27% over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 637.8, found 637.8. 
11s (X = Gln) (2.8 mg, 1.7 mol, 86%). Analytical HPLC conditions: Cosmosil 5C18-AR-II 
analytical column with a linear gradient of solvent B in solvent A, 5% to 35% over 30 min, retention 
time = 17.9 min. Preparative HPLC conditions: A linear gradient of solvent B in solvent A, 12% to 
27% over 30 min. MS (ESI-TOF) m/z calcd ([M+2H]2+) 644.8, found 644.8. 
 
Hydrazinolysis of Peptides 11a–s 
 
Representative procedure: To a solution of cyanylated peptide 11a (0.16 mg, 0.10 mol) in Milli-Q 
water (85 L) was added NH2NH2·H2O (15 L, final concentration 3 M) at 0 °C. The reaction was 
allowed to warm to room temperature. After 1 h incubation, progress of reaction was monitored by 
analytical HPLC. Fraction converted was determined by HPLC separation and integration of 12a 
(integ. 12a) as a fraction of the sum of integ. (12a + other detected peptides). 
In a manner similar to that described above, reaction of cyanopeptide 11a (0.79 mg, 0.50 mol) in 3 
M NH2NH2 solution at 0 °C to room temperature for 1 h, followed by semi-preparative HPLC gave 
the purified peptide hydrazide 12a (0.35 mg, 0.40 mol, 80%). 
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12a (X = Ala): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a linear 
gradient of solvent B in solvent A, 1% to 30% over 30 min, retention time = 22.1 min. MS 
(ESI-TOF) m/z calcd ([M+H]+) 649.4, found 649.4. 
12b (X = Gly): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a linear 
gradient of solvent B in solvent A, 1% to 30% over 30 min, retention time = 21.4 min. MS 
(ESI-TOF) m/z calcd ([M+H]+) 635.4, found 635.4. 
12c (X = Leu): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a linear 
gradient of solvent B in solvent A, 10% to 40% over 30 min, retention time = 18.8 min. MS 
(ESI-TOF) m/z calcd ([M+H]+) 691.4, found 691.4. 
12d (X = Val): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a linear 
gradient of solvent B in solvent A, 10% to 40% over 30 min, retention time = 15.2 min. MS 
(ESI-TOF) m/z calcd ([M+H]+) 677.4, found 677.4. 
12e (X = Ile): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a linear 
gradient of solvent B in solvent A, 10% to 40% over 30 min, retention time = 17.5 min. MS 
(ESI-TOF) m/z calcd ([M+H]+) 691.4, found 691.4. 
12f (X = Met): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a linear 
gradient of solvent B in solvent A, 1% to 35% over 30 min, retention time = 23.5 min. MS 
(ESI-TOF) m/z calcd ([M+H]+) 709.4, found 709.4. 
12g (X = Pro): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a linear 
gradient of solvent B in solvent A, 12% to 32% over 30 min, retention time = 12.9 min. MS 
(ESI-TOF) m/z calcd ([M+H]+) 675.4, found 675.3. 
12h (X = Phe): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a linear 
gradient of solvent B in solvent A, 10% to 40% over 30 min, retention time = 20.5 min. MS 
(ESI-TOF) m/z calcd ([M+H]+) 725.4, found 725.4. 
12i (X = Tyr): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a linear 
gradient of solvent B in solvent A, 10% to 40% over 30 min, retention time = 15.5 min. MS 
(ESI-TOF) m/z calcd ([M+H]+) 741.4, found 741.3. 
12j (X = Trp): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a linear 
gradient of solvent B in solvent A, 5% to 35% over 30 min, retention time = 25.5 min. MS 
(ESI-TOF) m/z calcd ([M + H]+) 764.4, found 764.4. 
12k (X = His): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a linear 
gradient of solvent B in solvent A, 1% to 30% over 30 min, retention time = 20.8 min. MS 
(ESI-TOF) m/z calcd ([M+H]+) 715.4, found 715.4. 
12l (X = Lys): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a linear 
gradient of solvent B in solvent A, 1% to 30% over 30 min, retention time = 20.4 min. MS 
(ESI-TOF) m/z calcd ([M+H]+) 706.4, found 706.4. 
16 
 
12m (X = Arg): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a linear 
gradient of solvent B in solvent A, 1% to 25% over 30 min, retention time = 23.8 min. MS 
(ESI-TOF) m/z calcd ([M+H]+) 734.4, found 734.4. 
12n (X = Ser): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a linear 
gradient of solvent B in solvent A, 1% to 30% over 30 min, retention time = 21.3 min. MS 
(ESI-TOF) m/z calcd ([M+H]+) 665.4, found 665.4. 
12o (X = Thr): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a linear 
gradient of solvent B in solvent A, 1% to 30% over 30 min, retention time = 21.9 min. MS 
(ESI-TOF) m/z calcd ([M+H]+) 679.4, found 679.4. 
12p (X = Asp): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a linear 
gradient of solvent B in solvent A, 1% to 30% over 30 min, retention time = 21.6 min. MS 
(ESI-TOF) m/z calcd ([M+H]+) 693.4, found 693.3. 
12q (X = Glu): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a linear 
gradient of solvent B in solvent A, 5% to 35% over 30 min, retention time = 17.5 min. MS 
(ESI-TOF) m/z calcd ([M+H]+) 707.4, found 707.3. 
12s (X = Gln): Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a linear 
gradient of solvent B in solvent A, 5% to 35% over 30 min, retention time = 16.6 min. MS 
(ESI-TOF) m/z calcd ([M+H]+), 706.4, found 706.3.  
 
Preparation of Peptide 19 
 
H-GCCGAFACDICGRKFARSDERKRHTKIHLRQKD-NH2 
                         19                          
 
Protected peptide resins corresponding to the title peptides were constructed on NovaSyn® TGR 
resin (Rink amide type: 0.22 mmol amine/g, 0.46 g, 0.10 mmol) using standard Fmoc SPPS. TFA 
cleavage (TFA–m-cresol–thioanisole–H2O–1,2-ethanedithiol (80:5:5:5:5 (v/v), 50 L/1 mg resin)) of 
the protected resin at room temperature for 2 h followed by HPLC purification afforded the desired 
peptide in 41% isolated yield. 
19: Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a linear gradient of 
solvent B in solvent A, 15% to 35% over 30 min, retention time = 18.0 min. Preparative HPLC 
conditions: A linear gradient of solvent B in solvent A, 20% to 30% over 30 min. MS (ESI-TOF) m/z 
calcd ([M+4H]4+) 952.0, found 951.7. 
 
Regioselective S-sulfonation of Peptide 19 followed by S-cyanylation  
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Peptide 19 (2.6 mol, 13.5 mg) was dissolved in a ZnCl2 solution (13.0 mol, 1.26 mL of a 10.4 
mM solution in 20 mM HEPPS buffer, pH = 7.0), and the mixture was stirred at room temperature 
for 15 min. Then, to the reaction mixture was added 20 mM HEPPS buffer containing Na2SO3 and 
Na2S4O6 (1.35 mL, pH = 7.0, Na2SO3 (1.2 mmol, 150 mg), Na2S4O6 (0.25 mmol, 67 mg)), and the 
solution was stirred again at room temperature for 24 h. The reaction progress was monitored by 
analytical HPLC, and the crude material was purified by semi-preparative HPLC to give 21. Without 
lyophilization, the resulting eluents were treated with CDAP (0.12 mmol, 27 mg), and the solution 
was stirred at room temperature for 3 h. The reaction progress was monitored by analytical HPLC 
followed by purification by semi-preparative HPLC to give 22 (6.8 mg, 1.3 mol, 2 steps 49%). 
21: Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a linear gradient of 
solvent B in solvent A, 15% to 35% over 30 min, retention time = 18.1 min. Preparative HPLC 
conditions: A linear gradient of solvent B in solvent A, 20% to 30% over 30 min. MS (ESI-TOF) m/z 
calcd ([M+3H]3+) 1322.3, found 1322.0. 
22: Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a linear gradient of 
solvent B in solvent A, 15% to 35% over 30 min, retention time = 18.1 min. Preparative HPLC 
conditions: A linear gradient of solvent B in solvent A, 20% to 30% over 30 min. MS (ESI-TOF) m/z 
calcd ([M+3H]3+) 1338.9, found 1338.4. 
 
Hydrazinolysis of Peptide 22 
 
To a solution of peptide 22 (5.2 mg, 0.97 mol) in Milli-Q water (0.83 mL) was added 
NH2NH2·H2O (0.14 mL, final concentration 3 M) at 0 °C. The reaction was allowed to warm to 
room temperature. After 1 h incubation, progress of reaction was monitored by analytical HPLC. 
23: Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a linear gradient of 
solvent B in solvent A, 1% to 35% over 30 min, retention time = 18.7 min. MS (ESI-TOF) m/z calcd 
([M+H] +) 802.2, found 802.0. 
 
NCL for the synthesis of 24 
 
Peptide thioester S1, H-RSCIDTIPKSRCTAFQ-S(CH2)2CO-L-NH2, (2.2 mol, 5.5 mg, see 
supporting information S2) and N-terminal cysteinyl peptide S2, 
H-CDICGRKFARSDERKRHTKIHLRQKD-NH2, (2.2 mol, 10.0 mg, see supporting 
information S2) were dissolved in 6 M Gn·HCl–0.2 M Na phosphate buffer containing 50 mM 
MPAA and 30 mM TCEP (pH 7.0, 2.2 mL, 1 mM each peptides). The reaction mixture was 
incubated at 37 °C for 6 h and reaction progress was monitored by analytical HPLC. The crude 
material was purified by preparative HPLC to give 24 (9.6 mg, 1.4 mol, 65%). 
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24: Analytical HPLC conditions: TSKgel Octadecyl-2PW analytical column with a linear gradient of 
solvent B in solvent A, 1% to 40% over 30 min, retention time = 18.3 min. Preparative HPLC 
conditions: A linear gradient of solvent B in solvent A, 15% to 30% over 30 min. MS (ESI-TOF) m/z 
calcd ([M+5H]5+) 1001.3, found 1000.9. 
 
Regioselective S-cyanylation of Peptide 24 
 
Peptide 24 (1.3 mol, 8.8 mg) was dissolved in 10 mM Na phosphate buffer (5.7 mL, pH = 7.5). A 
ZnSO4 solution (2.0 mol, 0.39 mL of a 5.0 mM solution in Milli-Q watter) was added, and the 
mixture was stirred at room temperature for 10 min under argon atmosphere. 6-nitroveratryl bromide 
(3.9 mol, 0.47 mL of a 8.3 mM solution in CH3CN) was added, and the solution was stirred under 
light-blocking conditions at room temperature for 2 h. To the reaction mixture was successively 
added solution of CDAP (63 mol, 1.5 mL of a 10 mg/mL solution in 0.1 M AcOH) and 0.1% TFA 
aq. (2.0 mL) to carry out S-cyanylation. After being stirred under light-blocking conditions at room 
temperature for 1.5 h, the reaction was purified by semi-preparative HPLC to give 26 (4.7 mg, 0.66 
mol, 51%) 
26: Analytical HPLC conditions: TSKgel Octadecyl-2PW analytical column with a linear gradient of 
solvent B in solvent A, 2% to 50% over 30 min, retention time = 19.0 min. Preparative HPLC 
conditions: A linear gradient of solvent B in solvent A, 20% to 35% over 30 min. MS (ESI-TOF) m/z 
calcd ([M+5H]5+) 1089.3, found 1088.9. 
 
Hydrazinolysis of Peptide 26 
 
To a solution of peptide 26 (0.66 mol, 4.7 mg) in Milli-Q water (0.56 mL) was added 
NH2NH2·H2O (98 L, final concentration 3 M) at 0 °C. The reaction was allowed to warm to room 
temperature. After 1 h incubation, the reaction was treated with 6M Gn·HCl containing 30 mM 
TCEP (2.5 mL). Then the crude material was purified by semi-preparative HPLC to give 27 (0.43 
mg, 0.15 mol, 23%). 
27: Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a linear gradient of 
solvent B in solvent A, 10% to 40% over 30 min, retention time = 23.6 min. Preparative HPLC 
conditions: A linear gradient of CH3CN in NH4OAc buffer (pH = 6.8), 10% to 40% over 30 min. MS 
(ESI-TOF) m/z calcd ([M+2H]2+) 1115.4, found 1115.1. 
28: Analytical HPLC conditions: TSKgel Octadecyl-2PW analytical column with a linear gradient of 
solvent B in solvent A, 2% to 50% over 30 min, retention time = 18.4 min. MS (ESI-TOF) m/z calcd 
([M+5H]5+) 1078.9, found 1078.5. 
28’: Analytical HPLC conditions: TSKgel Octadecyl-2PW analytical column with a linear gradient 
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of solvent B in solvent A, 2% to 50% over 30 min, retention time = 18.6 min. MS (ESI-TOF) m/z 
calcd ([M+5H]5+) 1079.3, found 1078.9. 
29: Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a linear gradient of 
solvent B in solvent A, 10% to 40% over 30 min, retention time = 25.4 min. MS (ESI-TOF) m/z 
calcd ([M+2H]2+) 1107.0, found 1106.7. 
 
NCL for the synthesis of 30 
 
Peptide thioester S3a (2.3 mol, 5.0 mg, see supporting information S2) and N-terminal cysteinyl 
peptide S2 (2.3 mol, 10.5 mg) were dissolved in 6 M Gn·HCl–0.2 M Na phosphate buffer 
containing 30 mM MPAA and 30 mM TCEP (pH 7.0, 2.3 mL, 1 mM each peptides). The reaction 
mixture was incubated at 37 °C for 7 h and reaction progress was monitored by analytical HPLC. 
The crude material was purified by preparative HPLC to give 30 (13.0 mg, 2.0 mol, 88%). 
30: Analytical HPLC conditions: TSKgel Octadecyl-2PW analytical column with a linear gradient of 
solvent B in solvent A, 2% to 50% over 30 min, retention time = 15.2 min. Preparative HPLC 
conditions: A linear gradient of solvent B in solvent A, 15% to 30% over 30 min. MS (ESI-TOF) m/z 
calcd ([M+5H]5+) 958.9, found 958.6. 
 
Regioselective S-cyanylation of Peptide 30 
 
Peptide 30 (2.0 mol, 13.0 mg) was dissolved in 10 mM Na phosphate buffer (5.7 mL, pH = 7.5). A 
ZnSO4 solution (3.1 mol, 0.61 mL of a 5.0 mM solution in Milli-Q watter) was added, and the 
mixture was stirred at room temperature for 10 min under argon atmosphere. 6-nitroveratryl bromide 
(3.4 mol, 0.80 mL of a 4.2 mM solution in CH3CN) was added, and the solution was stirred under 
light-blocking conditions at room temperature for 6 h. To the reaction mixture was successively 
added solution of CDAP (41 mol, 0.96 mL of a 10 mg/mL solution in 0.1 M AcOH) and 0.1% TFA 
aq. (2.0 mL) to carry out S-cyanylation. After being stirred under light-blocking conditions at room 
temperature for 1.5 h, the reaction was purified by semi-preparative HPLC to give 32 (7.3 mg, 1.1 
mol, 54%) 
31: Analytical HPLC conditions: TSKgel Octadecyl-2PW analytical column with a linear gradient of 
solvent B in solvent A, 2% to 50% over 30 min, retention time = 17.8 min. MS (ESI-TOF) m/z calcd 
([M+5H]5+) 997.9, found 997.6. 
32: Analytical HPLC conditions: TSKgel Octadecyl-2PW analytical column with a linear gradient of 
solvent B in solvent A, 2% to 50% over 30 min, retention time = 17.9 min. Preparative HPLC 
conditions: A linear gradient of solvent B in solvent A, 20% to 35% over 30 min. MS (ESI-TOF) m/z 
calcd ([M+5H]5+) 1007.9, found 1007.6. 
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Hydrazinolysis of Peptide 32 
 
Peptide 32 (0.76 mol, 5.1 mg) was dissolved in 33 mM Na phosphate buffer containing 1 M 
NH2NH2–1 M Gn·HCl (0.76 mL, pH = 10.4) at 0 °C. Then the mixture was incubated at room 
temperature under light-blocking conditions for 7 h, and reaction progress was monitored by 
analytical HPLC. The crude material was purified by semi-preparative HPLC to give 33 (0.67 mg, 
0.29 mol, 38%) and 34 (0.82 mg, 0.12 mol, 16%). 
 
33: Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a linear gradient of 
solvent B in solvent A, 5% to 35% over 30 min, retention time = 25.6 min. Preparative HPLC 
conditions: A linear gradient of solvent B in solvent A, 20% to 30% over 30 min. MS (ESI-TOF) m/z 
calcd ([M+2H]2+) 911.9, found 911.6. 
 
34: Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a linear gradient of 
solvent B in solvent A, 2% to 50% over 30 min, retention time = 20.4 min. Preparative HPLC 
conditions: A linear gradient of solvent B in solvent A, 20% to 30% over 30 min. MS (ESI-TOF) m/z 
calcd ([M+5H]5+) 997.9, found 997.6. 
 
Removal of NV for the synthesis of peptide hydrazide 35 
 
Peptide 33 (0.93 mg, 0.41 mol ) was dissolved in a photolysis buffer (0.82 mL, 50 mM 
semicarbazide hydrochloride, 20 mM L-(+)-ascorbic acid in 1:1 MeCN/0.1 M Na phosphate buffer, 
pH = 6.0). The mixed solution was flushed with argon, sealed and placed in photoreactor. The 
reaction was irradiated at 365 nm for up to 3 h. After confirmation of completion of the reaction by 
HPLC analysis, the solution was quenched with 6 M Gn·HCl containing 30 mM TCEP (2.0 mL) and 
incubated at 37 °C for 2 h. The crude material was purified by semi-preparative HPLC to give the 
purified peptide 35 (0.50 mg, 0.24 mol, 59%). 
 
35: Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a linear gradient of 
solvent B in solvent A, 5% to 35% over 30 min, retention time = 18.8 min. Preparative HPLC 
conditions: A linear gradient of solvent B in solvent A, 10% to 25% over 30 min. MS (ESI-TOF) m/z 
calcd ([M+2H]2+) 814.4, found 814.2. 
 
Conversion of Peptide hydrazide 35 to Peptide Thioester 36 
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Peptide 35 (0.55 mg, 0.26 mol) was dissolved in 0.2 M Na phosphate buffer containing 6 M 
Gn·HCl, (pH 3.0, 87 L). The reaction mixture was stored at –10 °C. Then, 8.7 L of 0.2 M NaNO2 
aq. was added, and the reaction mixture was incubated at –10 °C for 1 h. After that, 0.2 M Na 
phosphate buffer containing 6 M Gn·HCl and 0.2 M sodium 2-mercaptoethanesulfonate (87 L) was 
added, and pH of the mixed solution was adjusted to pH 7.0 with 4.0 M NaOH aq.. The reaction 
mixture was stored at room temperature for 30 min. The reaction was monitored by analytical HPLC. 
The crude material was purified by semi-preparative HPLC to give the purified peptide thioester 36 
(0.45 mg, 0.22 mol, 85%). 
 
36: Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a linear gradient of 
solvent B in solvent A, 5% to 35% over 30 min, retention time = 20.5 min. Preparative HPLC 
conditions: A linear gradient of solvent B in solvent A, 13% to 28% over 30 min. MS (ESI-TOF) m/z 
calcd ([M+2H]2+) 869.3, found 869.1. 
 
Preparation of SEAlide Peptide 37 
 
H-CFGYDNAYCDKLCKDKKADDGY-SEAlide 
                   37                    
 
The protected peptide resin was constructed on NovaSyn® TGR resin (Rink amide type: 0.25 mmol 
amine/g, 0.80 g, 0.20 mmol) using Fmoc SPPS (Acylation: Fmoc amino acid (5.0 equiv.), DIPCDI 
(5.0 equiv.) and Oxyma pure® (5.0 equiv.) in DMF or Fmoc-Tyr-incorporating SEAlinker S9 (2.0 
equiv., see supporting information S7), HATU (1.95 equiv.) and DIPEA (1.95 equiv.) in DMF for 2 
h; Fmoc removal: 20% piperadine/DMF for 10 min). The resulting completed resin was treated with 
TFA–m-cresol–thioanisole–H2O–1,2-ethanedithiol (80:5:5:5:5 (v/v), 50 L/1 mg resin) at room 
temperature for 2 h. The resin in the reaction mixture was filtrated off. To the resulting filtrate was 
added cooled Et2O to give precipitate. The formed precipitate was collected by centrifugation and 
thoroughly washed with Et2O to afford the crude SEAlide peptide 37. The crude SEAlide peptide 
was purified by preparative HPLC to give purified 37 in 36% isolated yield. 
37: Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a linear gradient of 
solvent B in solvent A, 10% to 40% over 30 min, retention time = 22.3 min. Preparative HPLC 
conditions: A linear gradient of solvent B in solvent A, 20% to 35% over 30 min. MS (ESI-TOF) m/z 
calcd ([M+3H]3+) 942.7, found 942.5. 
 
Preparation of N-terminal Cysteinyl TsTxV Fragment 38 
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H-CVWSPDCYCYGLPEHILKEPTKTSGRC-OH 
                    38                     
 
Protected peptide resins corresponding to the title peptides were constructed on Wang resin 
(0.70 mmol amine/g, 0.33 g, 0.23 mmol) using standard Fmoc SPPS. TFA cleavage 
(TFA–m-cresol–thioanisole–H2O–1,2-ethanedithiol (80:5:5:5:5 (v/v), 50 L/1 mg resin), at 
room temperature for 2 h followed by HPLC purification afforded the desired peptide 38 in 
28% isolated yield. 
38: Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a linear gradient of 
solvent B in solvent A, 15% to 45% over 30 min, retention time = 18.3 min. Preparative HPLC 
conditions: A linear gradient of solvent B in solvent A, 20% to 30% over 30 min. MS (ESI-TOF) m/z 
calcd ([M+3H]3+) 1029.1, found 1028.9. 
 
NCL for the Synthesis of Reduced Form TsTxV 
 
Ligation of peptide thioester 36 (0.45 mg, 0.22 mol) and SEAlide peptide 37 (0.71 mg, 0.21 mol) 
was performed in 6 M Gn·HCl–0.2 M HEPPS buffer containing 200 mM MPAA and 50 mM TCEP 
(pH = 7.0, 220 L, 1.0 mM each peptide). The reaction was completed within 3 h at 37 °C. After 
confirming the completion of the first NCL by HPLC analysis, 1.0 mM of peptide 38 (0.45 mg, 0.22 
mol) in 1.0 M Na phosphate buffer containing 50 mM TCEP (pH 7.1) was added to the reaction 
mixture to yield the desired reduced form TsTx-V in one-pot manner (final concentration: 3 M 
Gn·HCl, 0.1 M HEPPS, 0.5 M Na phosphate, 100 mM MPAA and 50 mM TCEP). After incubation 
at 37 °C for additional 48 h, the crude product was purified by semi-preparative HPLC to give the 
desired reduced form TsTxV (0.45 mg, 0.05 mol, 31%) 
39: Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a linear gradient of 
solvent B in solvent A, 16% to 40% over 30 min, retention time = 21.6 min. MS (ESI-TOF) m/z 
calcd ([M+4H]4+) 1106.0, found 1105.6. 
Reduced form TsTxV: Analytical HPLC conditions: Cosmosil 5C18-AR-II analytical column with a 
linear gradient of solvent B in solvent A, 16% to 40% over 30 min, retention time = 21.9 min. semi 
preparative HPLC conditions: A linear gradient of solvent B in solvent A, 26% to 36% over 30 min. 
MS (ESI-TOF) calcd (average isotopes) 7200.0, found 7199.7. 
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Scheme 1. S-Cyanylation-mediated reactions (A) and envisioned application to preparation of 
thioesters (B). 
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Scheme 2 Envisioned strategy for preparation of peptide thioesters using 
S-cyanylation/hydrazinolysis sequence 
 
 
 
27 
 
 
 
 
 
 
Figure 1 Production of peptide hydrazide fragment using regioselective 
S-cyanylation/hydrazinolysis sequence: (A) route for preparation of conotoxin thioester fragment 
and (B) HPLC monitoring of reactions. HPLC detected peptide 21 as a non-zinc-complexed form, 
because of the use of acidic eluents containing 0.1% TFA. 
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Figure 2 Reaction sequence for preparation of peptide hydrazide using 6-nitroveratryl group: (A) 
route for preparation of Stichodactyla toxin fragment and (B) HPLC monitoring of reactions. 
*Peptide 27 was co-eluted with peptide 28 in HPLC analysis. 
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Figure 3. Formation of diacyl hydrazide peptide from Gln-NHNH2 peptide under acidic conditions. 
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Figure 4 Conversion of TsTxV N-terminal fragment–zinc-finger fusion to peptide hydrazide: (A) 
route for preparation of TsTxV hydrazide fragment and (B) HPLC monitoring of reactions. 
*Itc-capped peptides: several peptides were generated by the presence of two cyanylation sites in 
peptide 32. 
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Figure 5 Conversion of TsTxV N-terminal hydrazide fragment to corresponding thioester: (A) route 
for preparation of TsTxV thioester fragment and (B) HPLC monitoring of reactions. *Non-peptidic 
material. 
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Figure 6 Synthesis of reduced form TsTxV by N–to–C-directed one-pot/sequential NCL protocol 
using SEAlide peptide. (A) Route for synthesis of TsTxV toxin: i) first NCL; ii) second NCL. (B) 
HPLC monitoring of reactions: i) first NCL, t < 1 min; ii) first NCL, t = 3 h; iii) second NCL, t < 1 
min; iv) second NCL, t = 48 h 
 
 
 
